Iovance Biotherapeutics, Inc. (IOVA) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Iovance Biotherapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -2.50x | -5.76x | -4.31x | -2.57x | -8.56x | -24.72x |
| P/B Ratio | 1.40x | 3.02x | 3.27x | 2.04x | 4.71x | 9.77x |
| P/S Ratio | 3.70x | 13.07x | 1607.75x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 97.2% | 24.4% | -804.5% | 0.0% | 0.0% | 0.0% |
| Operating Margin | -153.1% | -240.9% | -38735.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | -148.4% | -226.8% | -37345.4% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | -135.5% | -214.3% | -35948.9% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 3.20x | 3.74x | 2.79x | 5.24x | 5.69x | 11.59x |
| Quick Ratio | 2.83x | 3.31x | 2.70x | 5.24x | 5.69x | 11.59x |
| Leverage | ||||||
| Debt/Equity | 0.07x | 0.08x | 0.13x | 0.17x | 0.12x | 0.08x |
YoY = year-over-year change. Source: FMP..